Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754000 · ClinicalTrials.gov registry record
The AIM Study: Assessing the Impact of Margin Reduction
A clinical trial, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- 82
- Enrollment target
NCT00754000: Completed study, sponsored by Varian, a Siemens Healthineers Company.
NCT00754000 is a clinical trial that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00754000 has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be assessed at multiple time points for quality of life and side effects related to radiation therapy.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-09 |
What the finished NCT00754000 record still lists
NCT00754000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT00754000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00754000 about?
NCT00754000 is a clinical study titled "The AIM Study: Assessing the Impact of Margin Reduction". This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be asses...
What is the current status of trial NCT00754000?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2008-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00754000?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT00754000?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia